Compare BLLN & MAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | MAT |
|---|---|---|
| Founded | 2016 | 1945 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.5B |
| IPO Year | N/A | 1994 |
| Metric | BLLN | MAT |
|---|---|---|
| Price | $118.17 | $13.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $126.71 | $20.90 |
| AVG Volume (30 Days) | 782.3K | ★ 3.9M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $5,347,623,000.00 |
| Revenue This Year | $46.29 | $5.92 |
| Revenue Next Year | $30.14 | $5.08 |
| P/E Ratio | ★ N/A | $69.10 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $61.96 | $13.62 |
| 52 Week High | $138.70 | $22.48 |
| Indicator | BLLN | MAT |
|---|---|---|
| Relative Strength Index (RSI) | 67.16 | 39.65 |
| Support Level | $79.07 | N/A |
| Resistance Level | $138.70 | $15.38 |
| Average True Range (ATR) | 6.87 | 0.46 |
| MACD | 1.10 | -0.03 |
| Stochastic Oscillator | 97.91 | 20.62 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Mattel manufactures and markets toy products that are sold to its wholesale partners and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2025, with the remainder stemming from international markets.